PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.\', \'Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.\', \'Research Health Scientist, US Department of Veterans Affairs, Oklahoma City VA Health Care System, Oklahoma City, OK, USA.\', \'Instituto de Investigaciones Biomédicas en Retrovirus y Sida (INBIRS), Facultad de Medicina, Consejo de Investigaciones Científicas y Técnicas (CONICET), Universidad de Buenos Aires, Buenos Aires, Argentina. quarleri@fmed.uba.ar.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11357-021-00501-3
?:hasPublicationType
?:journal
  • GeroScience
is ?:pmid of
?:pmid
?:pmid
  • 34935099
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.168
?:rankingScore_hIndex
  • 45
?:title
  • Editorial: Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all